Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/10/06 15:41:30」(JST)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人における全身性エリテマトーデスの治療および予後の概要 overview of the therapy and prognosis of systemic lupus erythematosus in adults
2. 関節リウマチに対するリツキシマブおよびその他のB細胞標的療法 rituximab and other b cell targeted therapies for rheumatoid arthritis
3. 分類不能型低ガンマグロブリン血症の病因 pathogenesis of common variable immunodeficiency
4. 体液性免疫応答 the humoral immune response
5. 全身性エリテマトーデスの疫学および病因 epidemiology and pathogenesis of systemic lupus erythematosus

Molecular characterization and expression analysis of B cell activating factor from rock bream (Oplegnathus fasciatus).

Godahewa GI1, Perera NC1, Umasuthan N1, Wan Q2, Whang I3, Lee J4.
Developmental and comparative immunology.Dev Comp Immunol.2016 Feb;55:1-11. doi: 10.1016/j.dci.2015.10.004. Epub 2015 Oct 9.
B cell activating factor (BAFF) is a member of the tumor necrosis factor (TNF) ligand family. BAFF has been shown to induce survival and proliferation of lymphocytes. We characterized the gene encoding BAFF (RbBAFF) in rock bream (Oplegnathus fasciatus), and attempted to determine its biological fun
PMID 26455464

Plasmacytoid dendritic cells and myeloid cells differently contribute to B-cell-activating factor belonging to the tumor necrosis factor superfamily overexpression during primary HIV infection.

Borhis G1, Burelout C, Chaoul N, Smith N, Goujard C, Meyer L, Paul S, Saoudin H, Hosmalin A, Gilbert C, Herbeuval JP, Richard Y.
AIDS (London, England).AIDS.2016 Jan 28;30(3):365-76. doi: 10.1097/QAD.0000000000000965.
BACKGROUND: After describing heightened levels of circulating B-cell-activating factor belonging to the tumor necrosis factor superfamily (BAFF) as well as changes in B-cell phenotype and functions during acute infection by simian immunodeficiency virus, we wanted to determine whether and by which c
PMID 26558721

Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation.

Mujtaba MA1, Komocsar WJ2, Nantz E2, Samaniego MD3, Henson SL4, Hague JA5, Lobashevsky AL6, Higgins NG6, Czader M7, Book BK4, Anderson MD8, Pescovitz MD, Taber TE8.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.Am J Transplant.2016 Jan 18. doi: 10.1111/ajt.13557. [Epub ahead of print]
B cell-activation factor (BAFF) is critical for B cell maturation. Inhibition of BAFF represents an appealing target for desensitization of sensitized end-stage renal disease (ESRD) patients. We conducted a Phase 2a, single-arm, open-label exploratory study investigating the effect of tabalumab (BAF
PMID 26780484